...Good morning and welcome to Recursion Pharmaceuticals 2025 Annual Meeting of Stockholders. I am Christopher Gibson, Co-Founder and Chief Executive Officer, and President of Recursion, and a member of the Board of Directors. I will preside as Chair of this meeting, which I now call to order. This meeting is being conducted in a virtual meeting format only via the internet. I'm pleased to welcome you here today together with our Chairman, Robert Hershberg, on behalf of the Board of Directors. The other members of our Board are Zachary Bogue, Blake Borgeson, Namandje Bumpus, Zavain Dar, Najat Khan, Dean Li, Franziska Michor, and Elaine Sun. Joining me today for management, we have Ben Taylor, our Chief Financial Officer; and Nathan Hatfield, our Chief Legal Officer. Also with us are Megan King of PricewaterhouseCoopers LLP, our independent public accountants; Nathan Robinson of Wilson Sonsini Goodrich & Rosati, our Outside Corporate Counsel; and Chris Woods, a representative of Broadridge...